Investing.com - Ocular Therapeutix Inc reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Ocular Therapeutix Inc announced earnings per share of $-0.31 on revenue of $11.97M. Analysts polled by Investing.com EPS of $-0.23 on revenue of $14.6M.
Ocular Therapeutix Inc 's are up 100% and is trading at $3.55 , still down 54.83% from its 52 week high of $7.86 set on Tuesday, November 9, 2021.
Ocular Therapeutix Inc follows other major Healthcare sector earnings this month
Ocular Therapeutix Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar